NEXIEN BIOPHARMA, INC. Quarterly Current Ratio in % from Q3 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Nexien Biopharma, Inc. quarterly Current Ratio history and growth rate from Q3 2015 to Q3 2024.
  • Nexien Biopharma, Inc. Current Ratio for the quarter ending September 30, 2024 was 1.83 %, a 89.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 1.83 -15.2 -89.3% Sep 30, 2024
Q2 2024 3.23 -21.9 -87.1% Jun 30, 2024
Q1 2024 6.49 -27.4 -80.8% Mar 31, 2024
Q4 2023 10.4 -34.9 -77.1% Dec 31, 2023
Q3 2023 17 -31.2 -64.7% Sep 30, 2023
Q2 2023 25.1 -24.5 -49.4% Jun 30, 2023
Q1 2023 33.9 -16.2 -32.3% Mar 31, 2023
Q4 2022 45.3 +1.14 +2.58% Dec 31, 2022
Q3 2022 48.2 -79.2 -62.2% Sep 30, 2022
Q2 2022 49.6 -132 -72.6% Jun 30, 2022
Q1 2022 50.1 -157 -75.8% Mar 31, 2022
Q4 2021 44.2 -224 -83.5% Dec 31, 2021
Q3 2021 127 -194 -60.3% Sep 30, 2021
Q2 2021 181 -353 -66% Jun 30, 2021
Q1 2021 207 -517 -71.4% Mar 31, 2021
Q4 2020 268 -765 -74.1% Dec 31, 2020
Q3 2020 321 -1.11K -77.5% Sep 30, 2020
Q2 2020 534 -867 -61.9% Jun 30, 2020
Q1 2020 724 -619 -46.1% Mar 31, 2020
Q4 2019 1.03K -281 -21.4% Dec 31, 2019
Q3 2019 1.43K +171 +13.6% Sep 30, 2019
Q2 2019 1.4K Jun 30, 2019
Q1 2019 1.34K Mar 31, 2019
Q4 2018 1.31K Dec 31, 2018
Q3 2018 1.26K Sep 30, 2018
Q2 2017 84.4 +84.4 Jun 30, 2017
Q1 2017 0 0 Mar 31, 2017
Q4 2016 0 0 Dec 31, 2016
Q3 2016 0 0 Sep 30, 2016
Q2 2016 0 Jun 30, 2016
Q1 2016 0 Mar 31, 2016
Q4 2015 0 Dec 31, 2015
Q3 2015 0 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.